Farmaceutisch concern · India
Glenmark
Een concern van 27 bedrijven met 720 geneesmiddelen in 10 landen.
Concernstructuur
27 bedrijven in 14 landen
Laden…
Farmaceutisch concern · India
Een concern van 27 bedrijven met 720 geneesmiddelen in 10 landen.
27 bedrijven in 14 landen
Eén gratis account voor de Prognia-apps: Ward om te studeren, Osler voor klinische antwoorden met hun bronnen, en het netwerk om je collega’s te vinden.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Alle geneesmiddelen van alle bedrijven in het concern, actuele eerst.
1–25 van 720
| Geneesmiddel | Werkzame stof | Land | Status | Toelating |
|---|---|---|---|---|
| ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG676.401 mg + 300 mg · Comprimido recubierto con película | Abacavir, Lamivudine | Spanje | In de handel | 2017 |
| Abacavir/Lamivudine Glenmark 600 mg/300 mg filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Nederland | Toegelaten | 2017 |
| ABIRATERONA GLENMARK 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Abiraterone | Spanje | In de handel | 2021 |
| ABISAX 20 MG COMPRIMIDOS EFG20 mg · Comprimido | Bilastine | Spanje | In de handel | 2022 |
| ACAMPROSATE CALCIUM333mg · Tablet, delayed release | Acamprosate | Verenigde Staten | In de handel | 2013 |
| acetato de abiraterona | Abiraterone | Brazilië | Toegelaten | 2024 |
| Acitretina | Acitretin | Brazilië | Toegelaten | 2020 |
| ADACNE CLIN | Adapalene, Clindamycin | Brazilië | Toegelaten | 2007 |
| Adapaleen/Benzoylperoxide Glenmark 1 mg/g + 25 mg/g gelGel | Adapalene, Benzoyl peroxide | Nederland | Toegelaten | 2024 |
| Adapaleen/Benzoylperoxide Glenmark 3 mg/g + 25 mg/g gelGel | Adapalene, Benzoyl peroxide | Nederland | Toegelaten | 2024 |
| ADISOCOL 150 MG COMPRIMIDOS EFG150 mg · Comprimido | Ursodeoxycholic acid | Spanje | In de handel | 2018 |
| ADISOCOL 250 MG CAPSULAS DURAS EFG250 mg · Cápsula dura | Ursodeoxycholic acid | Spanje | Toegelaten | 2024 |
| ADISOCOL 300 MG COMPRIMIDOS EFG300 mg · Comprimido | Ursodeoxycholic acid | Spanje | In de handel | 2018 |
| ADISOCOL 450 MG COMPRIMIDOS EFG450 mg · Comprimido | Ursodeoxycholic acid | Spanje | In de handel | 2018 |
| ADISOCOL 500 MG CAPSULAS DURAS EFG500 mg · Cápsula dura | Ursodeoxycholic acid | Spanje | In de handel | 2024 |
| AEROGOLD | Salbutamol | Brazilië | Toegelaten | 2022 |
| Agomelatine Glenmark 25 mg filmomhulde tablettenFilmomhulde tablet | Agomelatine | Nederland | Toegelaten | 2018 |
| AILUK | Beclometasone | Brazilië | Toegelaten | 2022 |
| AILUK | Beclometasone | Brazilië | Toegelaten | 2022 |
| ALYACEN 1/350.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | Verenigde Staten | In de handel | 2012 |
| ALYACEN 7/7/70.035mg,0.035mg,0.035mg; 0.5mg,0.75mg,1mg · Tablet | Ethinyl estradiol, Norethindrone | Verenigde Staten | In de handel | 2012 |
| ALYACEN 7770.75mg; 0.035mg | 1mg; 0.035mg · Tablet | Norethindrone, Ethinyl estradiol | Verenigde Staten | In de handel | 2012 |
| ANAGRELIDA GLENMARK 0,5 MG CAPSULAS DURAS EFG0,61 mg · Cápsula dura | Anagrelide | Spanje | In de handel | 2018 |
| Anagrelide Glenmark 0,5 mg harde capsulesCapsule, hard | Anagrelide | Nederland | Toegelaten | 2018 |
| ANAMAP 25 MG/G + 25 MG/G CREMA25 mg + 25 mg · Crema | Lidocaine, Prilocaine | Spanje | In de handel | 2019 |
Waar het geneesmiddelen registreert of maakt, en hoeveel daarvan actueel zijn.
| Land | Geneesmiddelen | Actueel | Vroeger | Bedrijven |
|---|---|---|---|---|
| Nederland | 241 | 241 | 0 | BedrijvenAlle geneesmiddelen |
| Spanje | 202 | 152 | 50 | BedrijvenAlle geneesmiddelen |
| Brazilië | 123 | 32 | 91 | BedrijvenAlle geneesmiddelen |
| Verenigde Staten | 48 | 44 | 4 | BedrijvenAlle geneesmiddelen |
| Canada | 41 | 38 | 3 | BedrijvenAlle geneesmiddelen |
| Roemenië | 32 | 0 | 32 | BedrijvenAlle geneesmiddelen |
| Saoedi-Arabië | 20 | 20 | 0 | BedrijvenAlle geneesmiddelen |
| Singapore | 8 | 8 | 0 | BedrijvenAlle geneesmiddelen |
| Europese Unie (EMA) | 4 | 4 | 0 | BedrijvenAlle geneesmiddelen |
| Kroatië | 1 | 1 | 0 | BedrijvenAlle geneesmiddelen |
Ook geregistreerd in: Australië, Colombia, Frankrijk, Italië, Maleisië, Servië, Verenigd Koninkrijk, Zweden
De ATC-groepen waartoe de meeste van zijn geneesmiddelen behoren, grootste eerst.
De werkzame stoffen in de meeste van zijn geneesmiddelen.
Hoe de registers de naam schrijven, genormaliseerd: zonder rechtsvorm, accenten en hoofdletters.
Samengesteld door Prognia uit de openbare geneesmiddelen- en bedrijfsregisters hieronder. Logo’s worden niet gebruikt.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Source: European Medicines Agency (EPAR data).
Licentie: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licentie: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licentie: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licentie: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licentie: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licentie: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licentie: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licentie: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licentie: CC BY-SA 4.0
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IČO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Licentie: Czech statutory open data; ARES reuse and operating terms
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licentie: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licentie: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/parallel-import-licences-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licentie: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA parallel-import grant registers
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licentie: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licentie: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licentie: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licentie: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licentie: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licentie: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licentie: CC0
Meld een fout of vraag verwijdering aanCorrecties van het bedrijf zelf zijn welkom.
Houd de geneesmiddelen van Glenmark op Prognia juist, zie hoe zorgprofessionals ze gebruiken en beantwoord wat ze vragen. Een gesprek van 20 minuten, in het Engels.
Plan een gesprekBekende farmaceutische concerns, elk met al zijn bedrijven.
Gerangschikt naar hun aantal geneesmiddelen.